Dr. Rupert Vessey

Currently Dr. Rupert Vessey functions as head of early development and discovery sciences with Merck Research Laboratories, a research and development healthcare company. Dr. Vessey has been in the pharmaceutical industry since 1997, having begun his tenure working for GlaxoSmithKline (GSK) in the United Kingdom. During his time at GSK, he focused on drug discovery, experimental medicine, and early clinical development and contributed to projects involving DNA vaccines and monoclonal antibodies. Over the course of his subsequent career with Merck, Dr. Rupert Vessey has served in roles such as vice president of drug discovery and site head for Boston and Kenilworth.

A Fellow of the Royal College of Physicians in London, Dr. Rupert Vessey completed his education and clinical training in the United Kingdom. He earned his M.D. from Oxford University and his PhD from the Institute for Molecular Medicine. He also trained at the John Radcliffe Hospital and the National Hospital for Neurology and Neurosurgery, both in England.